01/13/2025
7:01 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2024
11:15 PM | Prime Medicine (Filer)
| Form EFFECT | |
12/13/2024
7:18 AM | Prime Medicine (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/09/2024
5:22 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
5:22 PM | Brudnick Richard (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
5:23 PM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:32 PM | ARCH Venture Fund XII, L.P. (Filed by)
Prime Medicine (Subject)
| Form SC 13D/A | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Prime Medicine (Subject)
| Form SC 13G/A | |
10/24/2024
7:04 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
3:29 PM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:20 PM | BRISTOL MYERS SQUIBB CO (Filed by)
Prime Medicine (Subject)
| Form SC 13G | |
Get the Latest News and Ratings for PRME and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter. |
09/30/2024
6:38 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:26 AM | Prime Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:08 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:18 PM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:11 PM | Brudnick Richard (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:11 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
7:05 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:22 AM | Prime Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/04/2024
8:20 PM | Marrazzo Jeffrey D (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:01 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
7:04 AM | Prime Medicine (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2024
7:09 AM | Prime Medicine (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024
3:21 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2023 GP, L.L.C. (Reporting)
GV 2023 GP, L.P. (Reporting)
GV 2023, L.P. (Reporting)
Prime Medicine (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/27/2024
8:35 AM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:01 PM | Alenson Carman (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:03 PM | Duffield Jeremy (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
8:31 PM | ARCH Venture Fund XII, L.P. (Filed by)
Prime Medicine (Subject)
| Form SC 13D | |
